Vyant Bio, Inc.
VYNT
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 68.77% | 57.79% | 44.47% | -135.62% | -162.04% |
| Total Depreciation and Amortization | -42.61% | -24.26% | -20.02% | 15.54% | 30.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -100.00% |
| Total Other Non-Cash Items | -95.26% | -89.49% | -71.27% | 536.76% | 616.39% |
| Change in Net Operating Assets | -297.75% | 46.20% | 133.16% | 138.80% | 120.92% |
| Cash from Operations | 10.33% | 6.48% | 19.49% | 13.35% | -0.09% |
| Capital Expenditure | 34.19% | -8.91% | -15.33% | -8.17% | 31.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -100.00% | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 95,400.00% | 9,971.79% | 44,011.11% | -226.00% | 0.00% |
| Cash from Investing | 1,075.06% | 697.40% | -88.74% | -102.31% | -101.30% |
| Total Debt Issued | -45.93% | -45.93% | -95.18% | -85.93% | -94.88% |
| Total Debt Repaid | -322.94% | -246.48% | -60.50% | -63.11% | 9.92% |
| Issuance of Common Stock | 1,137.84% | 1,137.84% | -- | 117.65% | -53.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 114.58% | 8.96% | -600.00% | -1,266.67% | -2,780.00% |
| Cash from Financing | 131.06% | 9.88% | -102.07% | -95.19% | -98.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39.76% | 30.38% | -153.33% | -164.99% | -155.84% |